Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin-targeted therapies. Hu ZI, Ghafoor A, Sengupta M, Hassan R, et al. Cancer 2021;127:1010-1020.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hu ZI, Ghafoor A, Sengupta M, Hassan R, et al. Malignant mesothelioma: Advances in immune checkpoint inhibitor and mesothelin-targeted therapies. Cancer 2021;127:1010-1020.
PMID: 33620732